KNSA: Kiniksa Pharmaceuticals International Plc Financial Statements

Balance sheet, income statement, and cash flow statements for Kiniksa Pharmaceuticals International Plc (KNSA).

OverviewDividends

$1.43B Market Cap.

As of 04/29/2025 5:00 PM ET (MRY) • Disclaimer

KNSA Market Cap. (MRY)


KNSA Shares Outstanding (MRY)


KNSA Assets (MRY)


Total Assets

$580.55M

Total Liabilities

$142.12M

Total Investments

$60.05M

KNSA Income (MRY)


Revenue

$423.24M

Net Income

-$43.19M

Operating Expense

$407.94M

KNSA Cash Flow (MRY)


CF Operations

$25.69M

CF Investing

$37.67M

CF Financing

$12.27M

KNSA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$580,553,000 (10.30%)

$526,322,000 (14.50%)

$459,672,000 (97.45%)

$232,800,000 (-33.38%)

Assets Current

$331,799,000 (20.09%)

$276,297,000 (13.67%)

$243,060,000 (23.73%)

$196,446,000 (-41.05%)

Assets Non-Current

$248,754,000 (-0.51%)

$250,025,000 (15.43%)

$216,612,000 (495.84%)

$36,354,000 (124.20%)

Goodwill & Intangible Assets

$16,250,000 (-5.80%)

$17,250,000 (-5.48%)

$18,250,000 (-5.19%)

$19,250,000 (0%)

Shareholders Equity

$438,436,000 (-0.09%)

$438,839,000 (10.78%)

$396,149,000 (114.09%)

$185,037,000 (-40.68%)

Property Plant & Equipment Net

$11,038,000 (-12.85%)

$12,665,000 (79.82%)

$7,043,000 (-15.99%)

$8,384,000 (-21.03%)

Cash & Equivalents

$183,581,000 (70.05%)

$107,954,000 (-12.03%)

$122,715,000 (0.20%)

$122,470,000 (7.20%)

Accumulated Other Comprehensive Income

-$163,000 (-2816.67%)

$6,000 (-86.36%)

$44,000 (166.67%)

-$66,000 (-94.12%)

Deferred Revenue

$31,811,000 (159.45%)

$12,261,000 (2.17%)

$12,000,000 (0%)

$0 (0%)

Total Investments

$60,046,000 (-38.99%)

$98,417,000 (44.96%)

$67,893,000 (13.66%)

$59,731,000 (-71.48%)

Investments Current

$60,046,000 (-38.99%)

$98,417,000 (44.96%)

$67,893,000 (13.66%)

$59,731,000 (-71.48%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$26,364,000 (-15.29%)

$31,122,000 (44.09%)

$21,599,000 (487.73%)

$3,675,000 (0%)

Trade & Non-Trade Receivables

$41,724,000 (96.20%)

$21,266,000 (67.98%)

$12,660,000 (217.69%)

$3,985,000 (0%)

Trade & Non-Trade Payables

$2,039,000 (-75.27%)

$8,246,000 (4.39%)

$7,899,000 (322.86%)

$1,868,000 (271.37%)

Accumulated Retained Earnings (Deficit)

-$521,143,000 (-9.04%)

-$477,950,000 (2.86%)

-$492,034,000 (27.15%)

-$675,397,000 (-30.52%)

Tax Assets

$211,151,000 (-3.71%)

$219,283,000 (18.22%)

$185,495,000 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$9,855,000 (-19.60%)

$12,258,000 (107.10%)

$5,919,000 (-2.17%)

$6,050,000 (-13.39%)

Debt Current

$1,993,000 (-11.54%)

$2,253,000 (-31.75%)

$3,301,000 (-2.37%)

$3,381,000 (60.47%)

Debt Non-Current

$7,862,000 (-21.42%)

$10,005,000 (282.16%)

$2,618,000 (-1.91%)

$2,669,000 (-45.28%)

Total Liabilities

$142,117,000 (62.45%)

$87,483,000 (37.72%)

$63,523,000 (33.00%)

$47,763,000 (27.27%)

Liabilities Current

$100,621,000 (58.05%)

$63,666,000 (35.27%)

$47,066,000 (5.00%)

$44,824,000 (40.75%)

Liabilities Non-Current

$41,496,000 (74.23%)

$23,817,000 (44.72%)

$16,457,000 (459.95%)

$2,939,000 (-48.28%)

KNSA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$423,239,000 (56.60%)

$270,259,000 (22.74%)

$220,180,000 (471.24%)

$38,544,000 (0%)

Cost of Revenue

$60,910,000 (82.33%)

$33,407,000 (45.91%)

$22,895,000 (151.59%)

$9,100,000 (0%)

Selling General & Administrative Expense

$168,011,000 (29.81%)

$129,427,000 (32.13%)

$97,951,000 (13.97%)

$85,948,000 (89.64%)

Research & Development Expense

$111,623,000 (46.69%)

$76,097,000 (16.20%)

$65,490,000 (-34.05%)

$99,297,000 (-11.38%)

Operating Expenses

$407,945,000 (55.68%)

$262,048,000 (39.75%)

$187,512,000 (0.77%)

$186,080,000 (18.25%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$7,041,000 (122.91%)

-$30,736,000 (82.17%)

-$172,337,000 (-12543.10%)

$1,385,000 (-73.12%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$43,193,000 (-406.68%)

$14,084,000 (-92.32%)

$183,363,000 (216.11%)

-$157,924,000 (2.14%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$43,193,000 (-406.68%)

$14,084,000 (-92.32%)

$183,363,000 (216.11%)

-$157,924,000 (2.14%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$43,193,000 (-406.68%)

$14,084,000 (-92.32%)

$183,363,000 (216.11%)

-$157,924,000 (2.14%)

Weighted Average Shares

$71,424,159 (1.95%)

$70,058,952 (0.98%)

$69,382,275 (1.17%)

$68,576,810 (10.89%)

Weighted Average Shares Diluted

$71,424,159 (-0.69%)

$71,922,915 (2.13%)

$70,421,322 (2.69%)

$68,576,810 (10.89%)

Earning Before Interest & Taxes (EBIT)

-$36,152,000 (-117.10%)

-$16,652,000 (-251.02%)

$11,026,000 (107.04%)

-$156,539,000 (-0.20%)

Gross Profit

$362,329,000 (52.98%)

$236,852,000 (20.06%)

$197,285,000 (570.03%)

$29,444,000 (0%)

Operating Income

-$45,616,000 (-81.04%)

-$25,196,000 (-357.81%)

$9,773,000 (106.24%)

-$156,636,000 (0.46%)

KNSA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$37,672,000 (227.46%)

-$29,557,000 (-265.90%)

-$8,078,000 (-106.28%)

$128,635,000 (648.69%)

Net Cash Flow from Financing

$12,266,000 (720.47%)

$1,495,000 (-40.58%)

$2,516,000 (-57.25%)

$5,885,000 (-97.41%)

Net Cash Flow from Operations

$25,689,000 (93.14%)

$13,301,000 (129.05%)

$5,807,000 (104.60%)

-$126,298,000 (7.50%)

Net Cash Flow / Change in Cash & Cash Equivalents

$75,627,000 (612.34%)

-$14,761,000 (-6124.90%)

$245,000 (-97.02%)

$8,222,000 (-87.75%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$37,924,000 (228.87%)

-$29,427,000 (-264.92%)

-$8,064,000 (-105.41%)

$149,050,000 (743.54%)

Capital Expenditure

-$252,000 (-93.85%)

-$130,000 (-828.57%)

-$14,000 (96.63%)

-$415,000 (-46.64%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$12,266,000 (720.47%)

$1,495,000 (-40.58%)

$2,516,000 (-57.25%)

$5,885,000 (-97.42%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$30,693,000 (13.05%)

$27,149,000 (8.08%)

$25,120,000 (-0.21%)

$25,173,000 (20.59%)

Depreciation Amortization & Accretion

$4,831,000 (-10.45%)

$5,395,000 (-0.88%)

$5,443,000 (9.17%)

$4,986,000 (31.04%)

KNSA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

85.60% (-2.28%)

87.60% (-2.23%)

89.60% (17.28%)

76.40%

Profit Margin

-10.20% (-296.15%)

5.20% (-93.76%)

83.30% (120.33%)

-409.70%

EBITDA Margin

-7.40% (-76.19%)

-4.20% (-156.00%)

7.50% (101.91%)

-393.20%

Return on Average Equity (ROAE)

-9.90% (-391.18%)

3.40% (-94.90%)

66.70% (195.56%)

-69.80% (-21.82%)

Return on Average Assets (ROAA)

-7.90% (-372.41%)

2.90% (-94.62%)

53.90% (191.82%)

-58.70% (-12.02%)

Return on Sales (ROS)

-8.50% (-37.10%)

-6.20% (-224.00%)

5.00% (101.23%)

-406.10%

Return on Invested Capital (ROIC)

-11.00% (-111.54%)

-5.20% (-177.61%)

6.70% (102.87%)

-233.10% (-167.32%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-32.97 (-137.59%)

87.7 (1445.65%)

5.67 (210.89%)

-5.12 (24.42%)

Price to Sales Ratio (P/S)

3.34 (-26.59%)

4.55 (-3.67%)

4.72 (-77.46%)

20.94

Price to Book Ratio (P/B)

3.26 (15.87%)

2.81 (6.92%)

2.63 (-40.00%)

4.38 (13.64%)

Debt to Equity Ratio (D/E)

0.32 (62.81%)

0.2 (24.38%)

0.16 (-37.98%)

0.26 (115.00%)

Earnings Per Share (EPS)

-0.6 (-400.00%)

0.2 (-92.42%)

2.64 (214.78%)

-2.3 (11.88%)

Sales Per Share (SPS)

5.93 (53.60%)

3.86 (21.59%)

3.17 (464.59%)

0.56 (0%)

Free Cash Flow Per Share (FCFPS)

0.36 (89.36%)

0.19 (126.51%)

0.08 (104.49%)

-1.85 (16.46%)

Book Value Per Share (BVPS)

6.14 (-2.01%)

6.26 (9.70%)

5.71 (111.64%)

2.7 (-46.51%)

Tangible Assets Book Value Per Share (TABVPS)

7.9 (8.74%)

7.27 (14.21%)

6.36 (104.30%)

3.11 (-44.89%)

Enterprise Value Over EBIT (EV/EBIT)

-37 (45.59%)

-68 (-186.08%)

79 (2075.00%)

-4 (42.86%)

Enterprise Value Over EBITDA (EV/EBITDA)

-42.83 (57.29%)

-100.28 (-289.28%)

52.98 (1379.71%)

-4.14 (43.57%)

Asset Turnover

0.77 (37.99%)

0.56 (-13.76%)

0.65 (352.45%)

0.14 (0%)

Current Ratio

3.3 (-24.01%)

4.34 (-15.96%)

5.16 (17.82%)

4.38 (-58.11%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$25,437,000 (93.13%)

$13,171,000 (127.36%)

$5,793,000 (104.57%)

-$126,713,000 (7.38%)

Enterprise Value (EV)

$1,341,365,956 (18.82%)

$1,128,870,729 (29.38%)

$872,533,795 (39.08%)

$627,378,880 (-43.90%)

Earnings Before Tax (EBT)

-$36,152,000 (-117.10%)

-$16,652,000 (-251.02%)

$11,026,000 (107.04%)

-$156,539,000 (-0.20%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$31,321,000 (-178.24%)

-$11,257,000 (-168.35%)

$16,469,000 (110.87%)

-$151,553,000 (0.57%)

Invested Capital

$289,956,000 (-17.09%)

$349,710,000 (25.99%)

$277,560,000 (430.65%)

$52,306,000 (-75.13%)

Working Capital

$231,178,000 (8.72%)

$212,631,000 (8.49%)

$195,994,000 (29.26%)

$151,622,000 (-49.69%)

Tangible Asset Value

$564,303,000 (10.85%)

$509,072,000 (15.33%)

$441,422,000 (106.71%)

$213,550,000 (-38.89%)

Market Capitalization

$1,428,146,956 (15.76%)

$1,233,734,729 (18.45%)

$1,041,585,795 (28.46%)

$810,816,880 (-32.59%)

Average Equity

$435,608,000 (5.88%)

$411,429,250 (49.62%)

$274,973,750 (21.46%)

$226,391,500 (-19.63%)

Average Assets

$549,488,000 (13.50%)

$484,144,750 (42.27%)

$340,291,500 (26.50%)

$269,006,250 (-12.62%)

Invested Capital Average

$327,265,500 (1.46%)

$322,569,250 (96.76%)

$163,938,000 (144.08%)

$67,165,500 (-62.52%)

Shares

72,201,565 (2.65%)

70,338,354 (1.16%)

69,531,762 (0.93%)

68,888,435 (1.19%)